What’s Wrong With the Merck Drug, Molnupiravir?

Why the FDA should not approve the drug.

  • Facebook
  • LinkedIn
  • Twitter
  • linkText
  • Email
This past week the drug maker Merck announced that it has a new pill that can significantly reduce the impacts of COVID-19 if taken early in the infection — preventing serious illness and hospitalization.

All that sounds well and good, but here’s the “problems” with the drug:

  • It was developed using scientific trails and so it should not be trusted.
  • Getting it adopted for medical use will require the Food and Drug Administration (FDA) to approve it for treatment of COVID-19.
  • This is the same FDA that has approved three vaccines for use against the coronavirus. If they approved those, why should we trust this new drug?
  • What’s to say that this drug won’t make you sterile?
  • What’s to say that there is not something in the pill that allows Bill Gates to track your movements?
  • Who’s to say this isn’t a grand experiment, like in the past, by white people against minorities? Whites must be getting a different version of the pill.
  • Why do we even need a drug like this, if the COVID-19 pandemic is huge hoax?
  • If you are young and healthy, why would you need to worry about getting sick or dying. You’ll live to be over the age of 80, right?
  • Finally, and most importantly, Dr. Fauci has touted the good news that comes from the development and manufacture of this drug. This makes it very suspect by anyone without a brain.

For others who don’t have the questions above, here is a story from Oct. 3: “Fauci sees hope in new Merck drug.”
  • Facebook
  • LinkedIn
  • Twitter
  • linkText
  • Email
Eric Holdeman is a contributing writer for Emergency Management magazine and is the former director of the King County, Wash., Office of Emergency Management.